Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Patent
1985-08-23
1987-10-13
Rosen, Sam
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C12D 100
Patent
active
046998756
ABSTRACT:
The present invention is based on the discovery that amyotrophic lateral sclerosis (ALS), Parkinson disease and Alzheimer disease are due to lack of a disorder-specific neurotrophic hormone. Diagnosis is accomplished by assaying hormones specific for a particular neuronal network or system: the motor neurotrophic hormones from muscle in the motor neural system are used to diagnose and treat ALS, dopamine neurotrophic hormones from striatum in the migrostriatal neural system are used to diagnose and treat parkinsonism, and cholinergic neurotrophic hormones released from the cortex and hippocampus which are specific for cholinergic neorons of the nucleus basalis and septal nucleus are used to diagnose and treat Alzheimer's disease. With tissue culture, the presence or absence of specific neurotrophic hormones can be assessed in ALS, parkinsonism, and Alzheimer disease. If there is a deficiency, extracted and purified neurotrophic hormones specific to the particular neuronal network or system can be injected in ALS and Alzheimer disease and in parkinsonism.
REFERENCES:
patent: 3989819 (1976-11-01), Brockman
Baylor College of Medicine
Rosen Sam
LandOfFree
Diagnosis of amyotrophic lateral sclerosis by neurotrophic facto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis of amyotrophic lateral sclerosis by neurotrophic facto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of amyotrophic lateral sclerosis by neurotrophic facto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-411297